The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.

Research shows that caffeine inhibits the action of some antibiotics, such as Avelox (moxifloxacin), Noroxin (norfloxacin), ...

The sale of antidepressants and mood elevators in India increased significantly, growing by 64% to Rs 2,536 crore since 2020, ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Discover how mindfulness practices can provide anxiety relief rivaling antidepressants, offering a natural alternative with fewer side effects.

Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

The data revealed that a combination of Escitalopram and Clonazepam was on top of the list, seeing an increase of 59.35% in sales since 2020.

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

A POPULAR nasal spray used to tackle a blocked nose may trigger Parkinson’s disease-like symptoms, a doctor has warned. Pseudoephedrine, a medicine found in many cold and flu medicines like ...

This training course will guide you through the principles of safe prescribing and demonstrate how to complete the National Standard Medication Charts correctly. The course comprises of 5 modules: ...

Depression and anxiety are among the most common complications of stroke. Is it time for new treatment guidance?